title: [Transrectal ultrasound-guided biopsy for prostate cancer: an update].
abstract: The prostate-specific antigen (PSA) test contributes a lot to the diagnosis and treatment of prostate cancer (PCa) and, along with imaging-guided prostate biopsy, has improved the diagnosis rate of lower-risk PCa and the accuracy of its clinical staging. However, many questions and controversies remain as to the choice of optimal biopsy strategies. Scholars differ in views about how to utilize PCa-related biomarkers to optimize the detection of initial and repeat biopsies. This review focuses on the present status of and advances in transrectal ultrasound-guided biopsy for PCa.
authors.forename: Zun-feng
authors.initials: ZF
authors.lastname: Fu
authors.forename: Xiu-fang
authors.initials: XF
authors.lastname: Duan
authors.forename: Xiu-hua
authors.initials: XH
authors.lastname: Yang
authors.forename: Xiu-yun
authors.initials: XY
authors.lastname: Wang
mesh_terms: D006801:Humans; D061705:Image-Guided Biopsy / Q000379:methods*; D008297:Male; D011467:Prostate / Q000473:pathology*; D017430:Prostate-Specific Antigen / Q000097:blood; D011471:Prostatic Neoplasms / Q000473:pathology*; D018084:Ultrasonography, Interventional / Q000379:methods
chemical_list: D017430:Prostate-Specific Antigen